Open Access<p>Association Between the HER2 Protein Expression Level and the Efficacy of Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer</p>
Author(s) -
Hui Yan,
Hui Xiao,
Jiujun Zhu,
Jingyang Zhang,
Zhenzhen Liu
Publication year - 2020
Publication title -
cancer management and research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.024
H-Index - 40
ISSN - 1179-1322
DOI - 10.2147/cmar.s278694
Subject(s) - trastuzumab , breast cancer , medicine , immunohistochemistry , oncology , chemotherapy , pathological , univariate analysis , cancer , logistic regression , odds ratio , multivariate analysis
This study aimed to assess the relationship between human epidermal growth factor receptor-2 (HER2) protein expression level and clinicopathological features of HER2-positive breast cancer, and to analyze whether the expression level of HER2 protein could predict the response to anti-HER2 therapy.